Gefitinib in Selected Patients with Pre-Treated Non-Small-Cell Lung Cancer: Results from a Phase IV, Multicenter, Non-Randomized Study (SELINE)

BACKGROUND: This study was designed to analyze the efficacy of gefitinib as a second-line therapy, according to the clinical characteristics in Korean patients with non-small-cell lung cancer (NSCLC). METHODS: In this Phase IV observational study, we recruited patients, previously failed first-line...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kwan-Ho, Lee, Kye-Young, Jeon, Young-June, Jung, Maan-Hong, Son, Choonhee, Lee, Min-Ki, Ryu, Jeong-Seon, Yang, Sei-Hoon, Lee, Jae-Cheol, Kim, Young-Chul, Kim, Sun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538183/
https://www.ncbi.nlm.nih.gov/pubmed/23319992
http://dx.doi.org/10.4046/trd.2012.73.6.303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538183/
https://www.ncbi.nlm.nih.gov/pubmed/23319992
http://dx.doi.org/10.4046/trd.2012.73.6.303

Ejemplares similares